Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. (Q48301370)

10 February 2018

title

Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. (English)

1 reference

10 February 2018

1 reference

Meythaler JM

1

1 reference

10 February 2018

Guin-Renfroe S

series ordinal

2

1 reference

10 February 2018

Grabb P

series ordinal

3

1 reference

10 February 2018

Hadley MN

series ordinal

4

1 reference

10 February 2018

publication date

1 January 1999

1 reference

10 February 2018

Archives of Physical Medicine and Rehabilitation

published in

1 reference

10 February 2018

volume

80

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

13-19

1 reference

10 February 2018

Drug therapy: spasticity (first of two parts).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Drug therapy: spasticity (second of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Segmental reflex pathways in spinal shock and spinal spasticity in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Continuous intrathecal baclofen infusion for spasticity of cerebral origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Use of intrathecal baclofen in the treatment of patients with dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Intrathecal baclofen and the H-reflex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Complications of baclofen withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Baclofen is antinociceptive in the spinal intrathecal space of animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Reduced spinal reflexes following intrathecal baclofen in the rabbit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Chronic intrathecal baclofen administration for control of severe spasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Intrathecal baclofen for severe spinal spasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Intrathecal baclofen: does tolerance occur?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Myorelaxant effect after intrathecal injection of antispastic drugs in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Modifiability of spinal synapses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Recurrent inhibition of alpha-motoneurons in patients with upper motor neuron lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Electrodiagnostic investigation of the motor neuron and spinal reflex arch (H-reflex) in spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Baclofen pseudopsychosis: case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

7 January 2021

Management of spasticity

2 references

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

7 January 2021

Voiding dysfunction in patients with spastic paraplegia: urodynamic evaluation and response to continuous intrathecal baclofen

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

Continuous intrathecal baclofen in spinal cord spasticity. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

7 January 2021

Studies in the Primate on the Analgetic Effects Associated with Intrathecal Actions of Opiates,α-Adrenergic Agonists and Baclofen

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

7 January 2021

Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990301-5

7 January 2021

10.1016/S0003-9993(99)90301-5

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9915366

1 reference

10 February 2018